Immunotherapy in Cancer: How Checkpoint Inhibitors Train Your Immune System to Destroy Tumors
The science of PD-1 / PD-L1 inhibitors (such as Pembrolizumab and Nivolumab). Dr. Advani explains why immunotherapy offers durable multi-year survival benefits for metastatic melanoma, lung, and bladder cancers.